Herbal medicinal product: Eucalypti aetheroleumArray,Array,Array, F: Assessment finalised
Herbal medicinal product: Eucalypti aetheroleumArray,Array,Array, F: Assessment finalised
Herbal medicinal product: Eucalypti aetheroleumArray,Array,Array, F: Assessment finalised
Template for a European Union herbal monograph
Committee for Advanced Therapies (CAT) meeting with interested parties, May 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, 16 May 2023
Cancer Medicines Forum: February 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, 26 February 2024
Guidance on real-world evidence provided by EMA: support for regulatory decision-making
Minutes of the 122nd meeting of the Management Board, 13-14 December 2023
Human medicines European public assessment report (EPAR): Eladynos, abaloparatide, Date of authorisation: 12/12/2022, Revision: 4, Status: Authorised
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2024
Emend (aprepitant) supply shortage
Draft guideline on the pharmaceutical quality of inhalation and nasal medicinal products